Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Apoteksgruppen i Stockholm Nr 4 AB
AB
In liquidation
Org 5568029168
Retail sale of pharmaceutical products
· NACE 4773
Est. 2010
5 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Apoteksgruppen i Stockholm Nr 4 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
5M
10M
16M
21M
18M
2016
18M
2017
15M
2018
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2016
0M
2017
-1M
2018
Income statement
SEK thousands
Item
2016
2017
2018
Revenue
17 722
17 628
15 087
Staff expenses
—
—
—
EBITDA
561
431
−1 309
Depreciation & amort.
−480
−463
−421
EBIT
81
−32
−1 730
Net financials
−14
−2
229
Profit before tax
67
−33
−11
Tax
−14
−0
−0
Net profit
53
−33
−11
Balance sheet
SEK thousands
Item
2016
2017
2018
Total assets
4 947
4 662
1 377
Equity
1 039
1 006
995
Long-term debt
0
0
0
Short-term debt
2 418
2 167
382
Total debt
2 418
2 167
382
Financial ratios
5-year trend
EBITDA margin
-8.7%
This company
15.8%
Market median
-155% vs market
2016
2018
Equity ratio
72.3%
This company
38.2%
Market median
+89% vs market
2016
2018
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
2016
2018
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
2016
2018
Asset turnover
10.96×
This company
1.12×
Market median
+879% vs market
2016
2018
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
More on Apoteksgruppen i Stockholm Nr 4 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot